The presently disclosed embodiments generally relate to the analysis of patient data, and more particularly, to a system and method for determining healthcare relationships.
Many nations spend an equivalent of over ten percent of a country's Gross Domestic Product (GDP) on healthcare each year. For example, in 2010, healthcare expenditures in the United States were equivalent to 17.9% of GDP. The Organization for Economic Co-operation and Development (OECD) estimates that developed countries spend, on average, 9.5% of GDP on healthcare.
Many patients with undiagnosed chronic conditions consume expensive services that treat ailments associated with their chronic condition without treating the underlying chronic condition itself. It has been estimated that these patients' overall medical costs can be up to six times higher pre-diagnosis than post-diagnosis. In other words, diagnosis of a chronic condition can lessen a patient's healthcare costs dramatically.
Today, health practitioners are generally not equipped to identify many of these chronic conditions at time of visit. If an undiagnosed chronic condition patient enters the emergency room seeking care for a specific symptom, a doctor may treat that specific symptom and release the patient without understanding how that specific symptom may be a sign of the chronic condition. That same patient might enter an emergency room with various symptoms over the course of months or even years without any individual doctor identifying that each symptom was associated with the same chronic condition that, if treated earlier on, could have removed the bulk of these emergency room visits.
For example, a patient may enter the emergency room one week for a bladder infection, a different emergency room the next week for headaches, and a third emergency room the third week with dry mouth. When each symptom is diagnosed individually, the diagnoses may be appropriate; however, that patient may have an underlying condition (e.g., diabetes) that may not be diagnosed because the symptoms were not analyzed on the whole. Accordingly, if the doctors from each of the different emergency rooms are not communicating with each other to diagnose the symptoms on the whole, the underlying condition may only be diagnosed after great expenditure by the patient chasing each symptom independently.
Additionally, there can also be warning signs for many chronic conditions that health practitioners are unable to identify for most patients. A patient with prediabetes may not have any particular symptoms associated with diabetes, but the patient may still have risk factors that increase the risk of that particular patient developing diabetes. For example, age, weight, waist size, inactivity, family history, race, gestational diabetes, blood pressure, and sleep patterns are all attributes that can be measured to determine a risk factor of developing diabetes. If a doctor does not sit down with a patient with prediabetes and discuss the totality of these risk factors, or if the patient is not able to provide a comprehensive report on the spot with the pertinent facts, the doctor might not identify the true risk of that particular patient developing diabetes. However, it is likely that the patient has disclosed the totality of these risk factors throughout that patient's history of healthcare through various encounters.
Accordingly, there exists a need for a system and method for determining healthcare relationships to identify healthcare cost savings opportunities and improved patient health outcomes.
In one aspect, a method for determining healthcare relationships includes ingesting, by a healthcare insight computing device, patient data of a patient received from one of a plurality of patient data providers; determining, by the healthcare insight computing device, one or more relationships between the ingested patient data and previously ingested patient data associated with the patient; correlating, by the healthcare insight computing device, the ingested data as a function of the determined relationships; enriching, by the healthcare insight computing device, the correlated patient data to form a new data element; and transmitting, by the healthcare insight computing device, the new data element to a raw data cluster.
In some embodiments, ingesting the patient data received from the patient data provider comprises staging the patient data in a data staging area. In other embodiments, determining the one or more relationships between the ingested patient data and the previously ingested patient data comprises determining the one or more relationships between the ingested patient data and the previously ingested patient data that has been received from another of the plurality of patient data providers.
In some embodiments, enriching the correlated patient data comprises supplementing the ingested patient data with referential data. In other embodiments, the method further includes extracting, by the healthcare insight computing device, at least a portion of the patient data from the raw data cluster in response to having received a request to generate a report associated with the patient data. Additionally or alternatively, in some embodiments, the method includes de-identifying, by the healthcare insight computing device, the extracted portion of the patient data; aggregating, by the healthcare insight computing device, the de-identified patient data as a function of the requested report; and presenting, by the healthcare insight computing device, a visual representation of the de-identified patient data as a function of the requested report and aggregated, de-identified patient data.
In some embodiments, the method additionally includes detecting, by the healthcare insight computing device, a previously identified relationship has been broken; and identifying, by the healthcare insight computing device, an alternative data path to form a new relationship with the patient data that was associated with the previously identified relationship.
The embodiments and other features, advantages and disclosures contained herein, and the manner of attaining them, will become apparent and the present disclosure will be better understood by reference to the following description of various exemplary embodiments of the present disclosure taken in conjunction with the accompanying drawings, wherein:
For the purposes of promoting an understanding of the principles of the present disclosure, reference will now be made to the embodiments illustrated in the drawings, and specific language will be used to describe the same. It will nevertheless be understood that no limitation of the scope of this disclosure is thereby intended.
This detailed description is presented in terms of programs, data structures, and/or procedures executed on a single computer or a network of computers. The software programs implemented by the system may be written in any programming language—interpreted, compiled, or otherwise. These languages may include, but are not limited to, PHP, ASP.net, HTML, HTML5, Ruby, Perl, Java, Python, C++, C#, JavaScript, and/or the Go programming language. It should be appreciated, of course, that one of skill in the art will appreciate that other languages may be used instead, or in combination with the foregoing and that web and/or mobile application frameworks may also be used, such as, for example, Ruby on Rails, Nodejs, Zend, Symfony, Revel, Django, Struts, Spring, Play, Jo, Twitter Bootstrap, and others. It should further be appreciated that the systems and methods disclosed herein may be delivered in a software-as-a-service (SaaS) model, made available over a computer network, such as, for example, the Internet. Further, the present disclosure may enable web services, application programming interfaces, and/or service-oriented architecture through one or more application programming interfaces (APIs) or other technologies.
In use, the healthcare insight computing device 108 receives various types of patient data from one or more of the patient data providers 102. The patient data may include any medical information related to a patient or healthcare provider (i.e., medical data), including, but not limited to provider information, physical characteristics of the patient(e.g., height, weight, race, etc.), medical history of the patient and/or family member (e.g., allergies, symptoms, diagnoses, treatments, lab results, outcomes, claims, etc.), and/or any other information related to the user that may be usable to perform the functions described herein, such as sleep patterns, activity levels, occupation, etc. Additionally, the patient data may include data referentially related to a patient (i.e., referential data), such as financial data, drug schedules, industry reference data, geographic data, etc. Accordingly, the patient data providers 102 may additionally include government agencies, financial institutions, industry organizations, census bureaus, etc.
It should be appreciated that the patient data may be pushed by one or more of the patient data providers 102 to the healthcare insight computing device 108 and/or pulled by the healthcare insight computing device 108 from one or more of the patient data providers 102 (e.g., from an electronic medical record database), depending on the embodiment. Due to the sensitive nature of the data being transmitted, it should be further appreciated that at least a portion of the patient data may be encrypted prior to transmission (e.g., to comply with government regulations, such as Health Insurance Portability and Accountability Act of 1996 (HIPAA)). The transmission of such patient data may be performed through web services, application programming interface (API), email, FTP, SFTP, or other data transfer processes. Additionally, data may be transmitted in various formats, such as a delimited text file (e.g., comma separated values (CSV) file, tab-separated values (TSV) file, etc.), Extensible Markup Language (XML), Health Level Seven International (HL7), or any other format.
Upon receiving the patient data, as further described in method 400 of
Additionally, the healthcare insight computing device 108 is configured to generate visualization report(s) usable to visualize the determined relationships/connections. For example, the visualization reports may be usable by healthcare providers to identify potential diagnoses of one or more patients, perform population health analysis, determine market conditions affecting pharmaceutical products, analyze the impact of programs on claims and testing behavior by healthcare providers, perform patient profiling, test innovations, etc.
As shown in the illustrative healthcare insight system 100 of
Referring now to
The CPU 200, or processor, may be embodied as any combination of hardware and circuitry capable of processing data. In some embodiments, the provider computing device 104 may include more than one CPU 200. Depending on the embodiment, the CPU 200 may include one processing core (not shown), such as in a single-core processor architecture, or multiple processing cores, such as in a multi-core processor architecture. Irrespective of the number of processing cores and CPUs 200, the CPU 200 is capable of reading and executing program instructions. In some embodiments, the CPU 200 may include cache memory (not shown) that may be integrated directly with the CPU 200 or placed on a separate chip with a separate interconnect to the CPU 200. It should be appreciated that, in some embodiments, pipeline logic may be used to perform software and/or hardware operations (e.g., network traffic processing operations), rather than commands issued to/from the CPU 200.
The I/O controller 202, or I/O interface, may be embodied as any type of computer hardware or combination of circuitry capable of interfacing between input/output devices and the provider computing device 104. Illustratively, the I/O controller 202 is configured to receive input/output requests from the CPU 200, and send control signals to the respective input/output devices, thereby managing the data flow to/from the provider computing device 104.
The memory 204 may be embodied as any type of computer hardware or combination of circuitry capable of holding data and instructions for processing. Such memory 204 may be referred to as main or primary memory. It should be appreciated that, in some embodiments, one or more components of the provider computing device 104 may have direct access to memory, such that certain data may be stored via direct memory access (DMA) independently of the CPU 200.
The network communication circuitry 206 may be embodied as any type of computer hardware or combination of circuitry capable of managing network interfacing communications (e.g., messages, datagrams, packets, etc.) via wireless and/or wired communication modes. Accordingly, in some embodiments, the network communication circuitry 206 may include a network interface controller (NIC) capable of being configured to connect the provider computing device 104 to a computer network (e.g., the network 106), as well as other devices, depending on the embodiment.
The one or more I/O peripherals 208 may be embodied as any auxiliary device configured to connect to and communicate with the provider computing device 104. For example, the I/O peripherals 208 may include, but are not limited to, a mouse, a keyboard, a monitor, a touchscreen, a printer, a scanner, a microphone, a speaker, etc. Accordingly, it should be appreciated that some I/O devices are capable of one function (i.e., input or output), or both functions (i.e., input and output).
In some embodiments, the I/O peripherals 208 may be connected to the provider computing device 104 via a cable (e.g., a ribbon cable, a wire, a universal serial bus (USB) cable, a high-definition multimedia interface (HDMI) cable, etc.) of the provider computing device 104. In such embodiments, the cable may be connected to a corresponding port (not shown) of the provider computing device 104 for which the communications made there between can be managed by the I/O controller 202. In alternative embodiments, the I/O peripherals 208 may be connected to the provider computing device 104 via a wireless mode of communication (e.g., Bluetooth®, Wi-Fi®, etc.) which can be managed by the network communication circuitry 206.
The data storage device 210 may be embodied as any type of computer hardware capable of the non-volatile storage of data (e.g., semiconductor storage media, magnetic storage media, optical storage media, etc.). Such data storage devices 210 are commonly referred to as auxiliary or secondary storage, and are typically used to store a large amount of data relative to the memory 204 described above.
Referring back to
The healthcare insight computing device 108 may be embodied as any type of compute and/or storage device capable of performing the functions described herein. For example, the healthcare insight computing device 108 may be embodied as, but is not limited to, one or more servers (e.g., stand-alone, rack-mounted, virtual, etc.), compute devices, cloud based compute services, storage devices, routers, switches, and/or combination of compute blades and data storage devices (e.g., of a storage area network (SAN)) in a cloud architected network or data center. As such, while the healthcare insight computing device 108 is illustrated as a single computing device, it should be appreciated that, in some embodiments, the healthcare insight computing device 108 may consist of more than one computing device (e.g., in a distributed computing architecture), each of which may be usable to perform at least a portion of the functions described herein.
It should be appreciated that the healthcare insight computing device 108 may contain like components to that of the illustrative provider computing device 104 of
The illustrative healthcare insight computing device 108 includes a healthcare insight platform 110. The healthcare insight platform 110 may be embodied as any combination of hardware, firmware, software, or circuitry usable to perform the functions described herein. In some embodiments, the healthcare insight platform 110 may be embodied as any type of network-based software application (e.g., cloud application, network application, software-as-a-service (SaaS) application, etc.) configured to communicate with the patient data providers 102, or more particularly the provider computing devices 104 (e.g., in a client-server architecture). Accordingly, in such embodiments, one or more of the provider computing devices 104 may execute a client application, which may be embodied as a thin client (e.g., a web browser, an email client, etc.) or thick client, that is configured to communicate with the healthcare insight platform 110 over the network 106 to provide one or more of the services described herein to a user. It should be appreciated that, in some embodiments, the user as referred to herein may refer to a person (i.e., a human user) or the provider computing device 104 itself.
The illustrative healthcare insight platform 110 includes a data refinery engine 112, a data cluster engine 114, and a report generation engine 116. In some embodiments, the data refinery engine 112, the data cluster engine 114, and/or the report generation engine 116 may include one or more computer-readable medium (e.g., the memory 204, the data storage device 210, and/or any other media storage device) having instructions stored thereon and one or more processors (e.g., the CPU 200) coupled with the one or more computer-readable medium and configured to execute instructions to perform the functions described herein.
The data refinery engine 112, which may be embodied as any type of firmware, hardware, software, circuitry, or combination thereof, is configured to move the patient data from individual databases through a self-discovery mechanism that processes information by performing logical transformations to transform the patient data for optimization purposes (e.g., to remove duplicate copies of repeating patient data). To do so, the data refinery engine 112 may be configured to cleanse, massage, and refine data sets for aggregation, master data management, calculate confidence scores, and determine quality scores. The data refinery engine 112 is additionally configured to enrich the patient data sets (i.e., apply enrichment data) through additional data sources (e.g., the referential data) and referential replacements, as further disclosed herein.
In practice, different healthcare providers may input tests, medications, etc., into their respective systems (e.g. provider computing device 104) using different names/codes. Under such conditions, the data refinery engine 112 is configured to derive relationships such that the different names/codes can be correlated, normalized, etc. In an illustrative example, a first healthcare provider sees a patient for a particular condition. Data entry of the patient's data is entered into the various healthcare provider systems (e.g., electronic medical record management software, billing system, etc.) by the first healthcare provider.
However, in doing so, the patient's address was incorrectly entered. Despite this error, the patient is able to receive clinical service and receives a prescription. Subsequently, a second healthcare provider sees that same patient and, as a result of the patient's address being incorrectly entered by the first healthcare provider, the second healthcare provider is unaware that the patient has already been prescribed a medication for the ailment from the first healthcare provider. Accordingly, the patient may be prescribed the same medication by both healthcare providers, unbeknownst to either healthcare provider. Under such conditions in which the medication prescribed is a controlled substance, both healthcare providers have unwittingly provided a potential drug abuser/seller with a double dose of the controlled substance.
However, if such data is received by the data refinery engine 112 as described herein, the data refinery engine 112 can establish a relationship across the patient data received from the two healthcare providers using data received from the various data entry systems. For example, a first relationship can be established across the data sets received from the first healthcare provider, such that the incorrect address may be detected and the data normalized based on a correlation determined between not only the patient data received from the first healthcare provider, but also the patient data received from the second healthcare provider for that patient.
Additionally, a confidence level (i.e., confidence score, confidence rating, etc.,) of the detected relationship can also be increased, or decreased, as more patient data is correlated across the different sources of patient data sets associated with that patient. It should be appreciated that the degree to which the confidence level is increased or decreased may be predicated upon a weight associated with the type of data being compared. For example, the confidence level of an address of a patient will likely be different than the confidence level of a social security number of a patient.
The data cluster engine 114, which may be embodied as any type of firmware, hardware, software, circuitry, or combination thereof, is configured to house the resulting sets of the logical transformations performed by the data refinery engine 112. Unlike present technologies, in which a data analyzer may only be aware of a single route between tables and/or missing data might not allow a connection between tables to be established, the data cluster engine 114 is further configured to self-heal patient data pathways, thereby optimizing relationships between the patient data. To do so, the data cluster engine 114 is configured to find an optimal query and reroute the query to find an alternative connection path if any data is missing.
Additionally, the data cluster engine 114 is configured to calculate a score representative of the optimal possible paths. For example, in some embodiments, the data cluster engine 114 may be configured to find the shortest path in a weighted graph applied to database referential integrity (e.g., using the uniform-cost search (UCS) algorithm). In such embodiments, the “distance” cost between two tables of patient data is calculated based on the count of the rows in the union of two tables, a count of industry identifiers used, and a granularity match score.
The report generation engine 116, which may be embodied as any type of firmware, hardware, software, circuitry, or combination thereof, is configured to provide a visualization of the insight of the patient data relationships gathered through the data refinery engine 112 and the data cluster engine 114. To do so, the report generation engine 116 is configured to perform aggregation, rollups, metric calculations, algorithms, confidence scoring, and additional manipulation of the patient data as may be required for reporting, dashboards, and data mining.
It should be appreciated that while the individual relationships associated with one patient provide insights into that particular patient, those individual relationships can be aggregated to offer additional healthcare relationships and insights. To do so, a user can, via an interface to the reporting engine 116, request a visualization of a particular set of patient data, or a result of one or more relationships identified across multiple sets of patient data. For example, healthcare and government entities can analyze the relationships drawn by not only the standardization of clinical data elements, such as the testing, but also understand events across a true representation of the population because there is integrity in the number of patients that are accounted for. In turn, the education and/or prevention campaigns can be distributed across a number of healthcare providers to apprise the healthcare providers of trends. Additionally, targeted education efforts can be made to better services dynamics of an affected area, such as age, gender, etc.
Referring now to
The data ingestion module 302, which may be embodied as any type of firmware, hardware, software, circuitry, or combination thereof, is configured to ingest the data. In other words, the data ingestion module 302 is configured to obtain and import the patient data. Accordingly, in some embodiments, the data ingestion module 302 may be configured to stage the received patient data in an intermediate storage area (i.e., a staging area, a landing zone, etc.) in which the patient data can be stored temporarily. It should be appreciated that the data ingestion module 302 may be configured to import the data in real time (e.g., a stream) and/or in batches of data, depending on the type of data and/or the patient data provider 102 from which the patient data is being received. As described previously, the patient data may include medical data (e.g., provider information, physical characteristics, medical history of the patient and/or family member, etc.) and referential data (e.g., financial data, drug schedules, industry reference data, geographic data, etc.).
In some embodiments, access to the patient data obtained by the data ingestion module 302 may require authorization and/or that such data be encrypted while in storage and/or transit. Accordingly, in such embodiments, one or more authentication and/or encryption technologies known to those of skill in the art may be employed by the data ingestion module 302 to ensure the storage and access to the data complies with any legal and/or contractual requirements.
The data correlation module 304, which may be embodied as any type of firmware, hardware, software, circuitry, or combination thereof, is configured to correlate the patient data. To do so, for example, the data correlation module 304 may be configured to apply one or more transformation algorithms, normalization operations, refinement operations, etc., to the patient data to determine one or more relationships across the patient data. The data correlation module 304 is additionally configured to determine a confidence level for each data element of the patient data received, which may be weighted based on the type of patient data for which the confidence level corresponds. Accordingly, based on the confidence level, a degree of confidence can be established for each relationship.
The data enrichment module 306, which may be embodied as any type of firmware, hardware, software, circuitry, or combination thereof, is configured to enrich the correlated data to generate a new data element. To do so, for example, the data enrichment module 306 may be configured to add referential data to the correlated data. As described previously, the referential data may include any data that may not be explicitly associated with the patient that may be usable to further establish relationships between data sets, such as financial data, drug schedules, industry reference data, geographic data, etc.
The raw data cluster interface module 308, which may be embodied as any type of firmware, hardware, software, circuitry, or combination thereof, is configured to interface with the raw data cluster 310. For example, the raw data cluster interface module 308 is configured to transmit, or otherwise perform an operation to store data elements in the raw data cluster 310. Additionally, the raw data cluster interface module 308 is configured to extract data from the raw data cluster, such as may be requested by the reporting engine 116 when providing a visual representation of the data to a user.
Referring now to
If patient data has been received, the method 400 advances to block 404, in which the data refinery engine 112 ingests the received patient data. To do so, in some embodiments, in block 406, the data refinery engine 112 stages the patient data in a staging area, or landing zone. In block 408, the data refinery engine 112 correlates the ingested patient data. To do so, the data refinery engine 112 may apply one or more transformation algorithms, normalization operations, refinement operations, etc., to the patient data to normalize the patient data and determine one or more relationships across the patient data. In block 410, the data refinery engine 112 enriches the correlated patient data to form a new data element (i.e., a master record). To do so, for example, the data refinery engine 112 may add referential data to the result of the patient data correlated in block 408. In block 412, the data refinery engine 112 transmits the new data element (i.e., a master record) to a raw data cluster (e.g., the raw data cluster 310 of
Referring now to
As described previously, the raw data cluster includes patient data that can be classified as protected health information (PHI) and/or personally identifying information. Accordingly, in block 506, the data cluster engine 114 determines whether to de-identify the data (i.e., prevent a patient's identity from being connected with the patient information presented in the report). If not, the method 500 jumps to block 512, described below; otherwise, the method 500 advances to block 508. It should be appreciated that, in such embodiments in which the raw patient data is not de-identified, authorization may be required by the respective patients before the patient data can be provided in raw format.
In block 508, the data cluster engine 114 de-identifies the extracted data. In other words, the data cluster engine 114 removes any PII/PHI from the extracted data such that it cannot be used to identify patients associated with the retrieved data. For example, the data cluster engine 114 may be configured to mask or delete identifying information (e.g., names, social security numbers, etc.) and/or suppressing/generalizing quasi-identifying information (e.g., date of birth, address, phone number, etc.). In block 510, the data cluster engine 114 aggregates the de-identified data as a function of the requested report.
In block 512, the report generation engine 116 presents a visual representation of the aggregated data as a function of the requested report. The visual representation may include graphical and/or pictorial representations of the aggregated data and/or relationships, which may be presented as a web page featuring one or more objects, an application window featuring graphical user interface (GUI) elements, etc., depending on the embodiment. In some embodiments, the visualization may be interactive, allowing a user to interface with the visual representation such that the user can visually see the data at a more abstracted or granular level.
While the present disclosure has been illustrated and described in detail in the drawings and foregoing description, the same is to be considered as illustrative and not restrictive in character, it being understood that only certain embodiments have been shown and described, and that all changes and modifications that come within the spirit of the present disclosure are desired to be protected.
This application claims priority to U.S. Provisional Patent Application No. 62/460,310, filed Feb. 17, 2017, which is incorporated in its entirety, by reference, herein.
Number | Name | Date | Kind |
---|---|---|---|
10558925 | Flor et al. | Feb 2020 | B1 |
20020042726 | Mayaud | Apr 2002 | A1 |
20030167189 | Lutgen et al. | Sep 2003 | A1 |
20040019502 | Leaman et al. | Jan 2004 | A1 |
20040122702 | Sabol | Jun 2004 | A1 |
20040122706 | Walker | Jun 2004 | A1 |
20050048666 | Larson et al. | Mar 2005 | A1 |
20050102159 | Mondshine | May 2005 | A1 |
20050108052 | Omaboe | May 2005 | A1 |
20050165623 | Landi et al. | Jul 2005 | A1 |
20070112586 | Dettinger | May 2007 | A1 |
20080015894 | Miller et al. | Jan 2008 | A1 |
20080022370 | Beedubail et al. | Jan 2008 | A1 |
20080046292 | Myers et al. | Feb 2008 | A1 |
20080140484 | Akerman | Jun 2008 | A1 |
20080228522 | Davis et al. | Sep 2008 | A1 |
20080280772 | Wong et al. | Nov 2008 | A1 |
20100076786 | Dalton et al. | Mar 2010 | A1 |
20100241448 | Firminger et al. | Sep 2010 | A1 |
20110082712 | Eberhardt, III et al. | Apr 2011 | A1 |
20110255782 | Welling et al. | Oct 2011 | A1 |
20110288886 | Whiddon et al. | Nov 2011 | A1 |
20110295621 | Farooq et al. | Dec 2011 | A1 |
20120022897 | Shafer | Jan 2012 | A1 |
20120191466 | Quint et al. | Jul 2012 | A1 |
20120203798 | Gifford et al. | Aug 2012 | A1 |
20120239430 | Corfield | Sep 2012 | A1 |
20120253139 | Maman et al. | Oct 2012 | A1 |
20120283546 | Zuehlsdorff et al. | Nov 2012 | A1 |
20120284052 | Saukas et al. | Nov 2012 | A1 |
20120303388 | Vishnubhatla et al. | Nov 2012 | A1 |
20130006668 | Arkel et al. | Jan 2013 | A1 |
20130080379 | Stergiou et al. | Mar 2013 | A1 |
20130179450 | Chitiveli | Jul 2013 | A1 |
20130197936 | Willich | Aug 2013 | A1 |
20130218592 | Hashmat | Aug 2013 | A1 |
20130310726 | Miller et al. | Nov 2013 | A1 |
20130346104 | Pillai | Dec 2013 | A1 |
20140002234 | Alwan | Jan 2014 | A1 |
20140012790 | Oberkampf et al. | Jan 2014 | A1 |
20140052460 | Grossman et al. | Feb 2014 | A1 |
20140067408 | Aach | Mar 2014 | A1 |
20140108024 | Evans et al. | Apr 2014 | A1 |
20140114676 | Holmes | Apr 2014 | A1 |
20140149128 | Getchius | May 2014 | A1 |
20140149139 | Bowen, Jr. et al. | May 2014 | A1 |
20140167917 | Wallace et al. | Jun 2014 | A2 |
20140236617 | Oberfest et al. | Aug 2014 | A1 |
20140246334 | Bosch et al. | Sep 2014 | A1 |
20140279807 | Dimitrijevic | Sep 2014 | A1 |
20140324825 | Gopinath et al. | Oct 2014 | A1 |
20140357961 | Meltzer et al. | Dec 2014 | A1 |
20150039344 | Kinney et al. | Feb 2015 | A1 |
20150058028 | Su et al. | Feb 2015 | A1 |
20150058039 | Shiloh | Feb 2015 | A1 |
20150066910 | Bleach | Mar 2015 | A1 |
20150088540 | Lo et al. | Mar 2015 | A1 |
20150100349 | Lacy et al. | Apr 2015 | A1 |
20150193583 | McNair | Jul 2015 | A1 |
20150213206 | Amarasingham et al. | Jul 2015 | A1 |
20150213223 | Amarasingham et al. | Jul 2015 | A1 |
20150286792 | Gardner et al. | Oct 2015 | A1 |
20150324527 | Siegel et al. | Nov 2015 | A1 |
20150379201 | Varadarajan | Dec 2015 | A1 |
20160004820 | Moore | Jan 2016 | A1 |
20160019349 | Ross et al. | Jan 2016 | A1 |
20160092641 | Delaney et al. | Mar 2016 | A1 |
20160117468 | Mankad et al. | Apr 2016 | A1 |
20160125170 | Abramowitz | May 2016 | A1 |
20160147945 | MacCarthy et al. | May 2016 | A1 |
20160188822 | Ryan et al. | Jun 2016 | A1 |
20160243359 | Sharma | Aug 2016 | A1 |
20160350919 | Steigauf et al. | Dec 2016 | A1 |
20160357910 | Ghouri et al. | Dec 2016 | A1 |
20170061152 | Bostic et al. | Mar 2017 | A1 |
20170083681 | Sprintz et al. | Mar 2017 | A1 |
20170116389 | Matlin et al. | Apr 2017 | A1 |
20170169173 | Snow, Jr. et al. | Jun 2017 | A1 |
20170169175 | Graff et al. | Jun 2017 | A1 |
20170277838 | Derer | Sep 2017 | A1 |
20170286621 | Cox et al. | Oct 2017 | A1 |
20170300648 | Charlap | Oct 2017 | A1 |
20170308652 | Ligon | Oct 2017 | A1 |
20180001184 | Tran et al. | Jan 2018 | A1 |
20180020186 | Gurmu | Jan 2018 | A1 |
20180039731 | Szeto | Feb 2018 | A1 |
20180114595 | Stern | Apr 2018 | A1 |
20180121606 | Allen et al. | May 2018 | A1 |
20180137244 | Sorenson et al. | May 2018 | A1 |
20180166172 | Fidone et al. | Jun 2018 | A1 |
20180174673 | Defrank et al. | Jun 2018 | A1 |
20180197625 | Lobach | Jul 2018 | A1 |
20180253840 | Tran | Sep 2018 | A1 |
20180261325 | Nanos | Sep 2018 | A1 |
20180330060 | Biles et al. | Nov 2018 | A1 |
20180330824 | Athey et al. | Nov 2018 | A1 |
20180333063 | Muchhala et al. | Nov 2018 | A1 |
20180342324 | Cha et al. | Nov 2018 | A1 |
20180374580 | Gupta et al. | Dec 2018 | A1 |
20190005187 | Costello et al. | Jan 2019 | A1 |
20190005195 | Peterson et al. | Jan 2019 | A1 |
20190026438 | Ma et al. | Jan 2019 | A1 |
20190108912 | Spurlock, III et al. | Apr 2019 | A1 |
20190138692 | Guo et al. | May 2019 | A1 |
20190188410 | Briscoe et al. | Jun 2019 | A1 |
20190198144 | Blackley et al. | Jun 2019 | A1 |
20190198169 | Satyanarayana et al. | Jun 2019 | A1 |
20190214145 | Kurek et al. | Jul 2019 | A1 |
20190287679 | Beck et al. | Sep 2019 | A1 |
20190304604 | Kupersmith et al. | Oct 2019 | A1 |
20190355451 | Clark | Nov 2019 | A1 |
20190355479 | Carlson et al. | Nov 2019 | A1 |
20190355481 | Lamb et al. | Nov 2019 | A1 |
20190385738 | Hoelzer et al. | Dec 2019 | A1 |
20200004746 | Randall et al. | Jan 2020 | A1 |
20200335224 | Sreenivasan et al. | Oct 2020 | A1 |
Number | Date | Country |
---|---|---|
2013122979 | Aug 2013 | WO |
2015148614 | Oct 2015 | WO |
Entry |
---|
PCT International Search Report and Written Opinion dated Jul. 2, 2015 for International Application No. PCT/US2015/022408, 9 pages. |
U.S. Appl. No. 15/120,208, filed Aug. 19, 2016, Bostic et al. |
Centers for Disease Control and Prevention, “Calculating Total Daily Dose of Opiods for Safer Dosage,” https://web.archive.org/web/20171209014431/https://www.cdc.gov/drugoverdose/pdf/calculating_total_daily_dose-a.pdf, Dec. 2017, 2 pages. |
U.S. Appl. No. 17/204,611, filed Mar. 17, 2021, Bostic et al.. |
U.S. Appl. No. 17/205,005, filed Mar. 18, 2021, Bostic et al.. |
U.S. Appl. No. 17/205,049, filed Mar. 18, 2021, Bostic et al.. |
U.S. Appl. No. 17/205,068, filed Mar. 18, 2021, Bostic et al.. |
U.S. Appl. No. 17/203,984, filed Mar. 17, 2021, Bostic et al.. |
U.S. Appl. No. 17/204,019, filed Mar. 17, 2021, Bostic et al.. |
U.S. Appl. No. 17/204,040, filed Mar. 17, 2021, Bostic et al.. |
U.S. Appl. No. 17/204,070, filed Mar. 17, 2021, Bostic et al.. |
U.S. Appl. No. 17/204,081, filed Mar. 17, 2021, Bostic et al.. |
U.S. Appl. No. 17/204,104, filed Mar. 17, 2021, Bostic et al.. |
U.S. Appl. No. 17/204,131, filed Mar. 17, 2021, Bostic et al. |
U.S. Appl. No. 17/205,013, filed Mar. 18, 2021, Bostic et al.. |
U.S. Appl. No. 17/205,033, filed Mar. 18, 2021, Bostic et al.. |
U.S. Appl. No. 17/205,105, filed Mar. 18, 2021, Bostic et al. |
U.S. Appl. No. 17/205,126, filed Mar. 18, 2021, Bostic et al.. |
U.S. Appl. No. 16/778,377, filed Jan. 31, 2020, Bostic et al.. |
U.S. Appl. No. 16/825,396, filed Mar. 20, 2020, Bostic et al.. |
U.S. Appl. No. 17/023,516, filed Sep. 17, 2020, Bostic et al.. |
U.S. Appl. No. 17/204,557, filed Mar. 17, 2021, Bostic et al.. |
U.S. Appl. No. 16/535,863, filed Aug. 8, 2019, Bostic et al.. |
Number | Date | Country | |
---|---|---|---|
20180240536 A1 | Aug 2018 | US |
Number | Date | Country | |
---|---|---|---|
62460310 | Feb 2017 | US |